Variation at extra-epitopic amino acid residues influences suppression of influenza virus replication by M158-66 epitope-specific CD8+ T lymphocytes

Journal of Virology

Volumn 92, Issue 11, 2018, Pages

  van de Sandt, Carolien E ^a,c   Pronk, Mark R ^a   van Baalen, Carel A ^b   Fouchier, Ron A M ^a   Rimmelzwaan, Guus F ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Viro Clinics Bio Sciences BV   (Netherlands)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

CD8+ T lymphocytes; Evasion; Extra epitopic amino acid residues; Influenza A virus; Replication

Indexed keywords

AMINO ACID; EPITOPE; VIRAL PROTEIN; HLA A2 ANTIGEN; HLA-A*02:01 ANTIGEN; M1 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN;

ARTICLE; AVIAN INFLUENZA VIRUS; CD8+ T LYMPHOCYTE; CELL CLONING; COCULTURE; EPITHELIUM CELL; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; INFLUENZA VIRUS; M1 GENE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CULTURE; VIRUS GENE; VIRUS REPLICATION; A-549 CELL LINE; ANIMAL; DOG; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H5N1); MDCK CELL LINE; TUMOR CELL LINE; VIROLOGY;

A549 CELLS; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DOGS; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

EID: 85046902977     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00232-18     Document Type: Article

References (37)

1. WHO. 2018. Influenza (seasonal) fact sheet. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs211/en/
2. Chen R, Holmes EC. 2008. The evolutionary dynamics of human influenza B virus. J Mol Evol 66:655-663. https://doi.org/10.1007/s00239-008-9119-z
3. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979. https://doi.org/10.1126/science.1244730
4. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. https://doi.org/10.1126/science.1097211
5. Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kuhnert D, Boskova V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ, Barr IG. 2015. The contrasting phylodynamics of human influenza B viruses. Elife 4:e05055. https://doi.org/10.7554/eLife.05055
6. Zhang R, Rong X, Pan W, Peng T. 2011. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1. Scand J Infect Dis 43: 216-220. https://doi.org/10.3109/00365548.2010.539258
7. van de Sandt CE, Kreijtz JH, Rimmelzwaan GF. 2012. Evasion of influenza A viruses from innate and adaptive immune responses. Viruses 4:1438-1476. https://doi.org/10.3390/v4091438
8. Quinones-Parra S, Loh L, Brown LE, Kedzierska K, Valkenburg SA. 2014. Universal immunity to influenza must outwit immune evasion. Front Microbiol 5:285. https://doi.org/10.3389/fmicb.2014.00285
9. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2008. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82:5161-5166. https://doi.org/10.1128/JVI.02694-07
10. van de Sandt CE, Kreijtz JH, de Mutsert G, Geelhoed-Mieras MM, Hillaire ML, Vogelzang-van Trierum SE, Osterhaus AD, Fouchier RA, Rimmelzwaan GF. 2014. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol 88:1684-1693. https://doi.org/10.1128/JVI.02843-13
11. Quinones-Parra S, Grant E, Loh L, Nguyen TH, Campbell KA, Tong SY, Miller A, Doherty PC, Vijaykrishna D, Rossjohn J, Gras S, Kedzierska K. 2014. Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc Natl Acad Sci U S A 111:1049-1054. https://doi.org/10.1073/pnas.1322229111
12. van de Sandt CE, Dou Y, Vogelzang-van Trierum SE, Westgeest KB, Pronk MR, Osterhaus AD, Fouchier RA, Rimmelzwaan GF, Hillaire ML. 2015. Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage. J Gen Virol 96:2061-2073. https://doi.org/10.1099/vir.0.000156
13. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, Bean T, Barclay W, Deeks JJ, Lalvani A. 2013. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 19:1305-1312. https://doi.org/10.1038/nm.3350
14. Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, Dukes O, Millett ER, Nazareth I, Nguyen-Van-Tam JS, Watson JM, Zambon M, Flu Watch Group, Johnson AM, McMichael AJ. 2015. Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the Flu Watch Cohort study. Am J Respir Crit Care Med 191:1422-1431. https://doi.org/10.1164/rccm.201411-1988OC
15. Wang Z, Wan Y, Qiu C, Quinones-Parra S, Zhu Z, Loh L, Tian D, Ren Y, Hu Y, Zhang X, Thomas PG, Inouye M, Doherty PC, Kedzierska K, Xu J. 2015. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells. Nat Commun 6:6833. https://doi.org/10.1038/ncomms7833
16. Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. 2004. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virusspecific cytotoxic T-lymphocyte response in vitro. J Virol 78:5216-5222. https://doi.org/10.1128/JVI.78.10.5216-5222.2004
17. Berkhoff EG, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2007. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones. J Gen Virol 88:530-535. https://doi.org/10.1099/vir.0.82120-0
18. Price GE, Ou R, Jiang H, Huang L, Moskophidis D. 2000. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. J Exp Med 191:1853-1867. https://doi.org/10.1084/jem.191.11.1853
19. Rimmelzwaan GF, Boon AC, Voeten JT, Berkhoff EG, Fouchier RA, Osterhaus AD. 2004. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res 103: 97-100. https://doi.org/10.1016/j.virusres.2004.02.020
20. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2000. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74:6800-6807. https://doi.org/10.1128/JVI.74.15.6800-6807.2000
21. Berkhoff EG, Geelhoed-Mieras MM, Verschuren EJ, van Baalen CA, Gruters RA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2007. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro. Clin Exp Immunol 148:296-306. https://doi.org/10.1111/j.1365-2249.2007.03340.x
22. Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. 2002. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 76:2567-2572. https://doi.org/10.1128/jvi.76.5.2567-2572.2002
23. Berkhoff EG, de Wit E, Geelhoed-Mieras MM, Boon AC, Symons J, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2005. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J Virol 79:11239-11246. https://doi.org/10.1128/JVI.79.17.11239-11246.2005
24. Berkhoff EG, de Wit E, Geelhoed-Mieras MM, Boon AC, Symons J, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2006. Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses. Vaccine 24:6594-6596. https://doi.org/10.1016/j.vaccine.2006.05.051
25. Cao S, Liu X, Yu M, Li J, Jia X, Bi Y, Sun L, Gao GF, Liu W. 2012. A nuclear export signal in the matrix protein of influenza A virus is required for efficient virus replication. J Virol 86:4883-4891. https://doi.org/10.1128/JVI.06586-11
26. Terajima M, Ennis FA. 2012. Nuclear export signal and immunodominant CD8+ T cell epitope in influenza A virus matrix protein 1. J Virol 86:10258. https://doi.org/10.1128/JVI.00894-12
27. van de Sandt CE, Kreijtz JH, Geelhoed-Mieras MM, Nieuwkoop NJ, Spronken MI, van de Vijver DA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2016. Differential recognition of influenza A viruses by M158-66 epitope-specific CD8+ T cells is determined by extraepitopic amino acid residues. J Virol 90:1009-1022. https://doi.org/10.1128/JVI.02439-15
28. van Baalen CA, Jeeninga RE, Penders GH, van Gent B, van Beek R, Koopmans MP, Rimmelzwaan GF. 2017. ViroSpot microneutralization assay for antigenic characterization of human influenza viruses. Vaccine 35:46-52. https://doi.org/10.1016/j.vaccine.2016.11.060
29. Goto H, Kawaoka Y. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A 95:10224-10228
30. Bodewes R, Geelhoed-Mieras MM, Nieuwkoop NJ, Hanson JA, David CS, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2011. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLAB* 2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis. Virus Res 155:123-130. https://doi.org/10.1016/j.virusres.2010.09.008
31. Rimmelzwaan GF, Boon AC, Geelhoed-Mieras MM, Voeten JT, Fouchier RA, Osterhaus AD. 2004. Human airway epithelial cells present antigen to influenza virus-specific CD8+ CTL inefficiently after incubation with viral protein together with ISCOMATRIX. Vaccine 22:2769-2775. https://doi.org/10.1016/j.vaccine.2004.01.052
32. Rimmelzwaan GF, Nieuwkoop N, Brandenburg A, Sutter G, Beyer WE, Maher D, Bates J, Osterhaus AD. 2000. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 19:1180-1187. https://doi.org/10.1016/S0264-410X(00)00310-8
33. Voeten JT, Rimmelzwaan GF, Nieuwkoop NJ, Lovgren-Bengtsson K, Osterhaus AD. 2000. Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes. Vaccine 19:514-522. https://doi.org/10.1016/S0264-410X(00)00179-1
34. Boon AC, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2006. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity. J Virol 80:6024-6032. https://doi.org/10.1128/JVI.00009-06
35. de Wit E, Spronken MI, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res 103:155-161. https://doi.org/10.1016/j.virusres.2004.02.028
36. Rimmelzwaan GF, Baars M, Claas EC, Osterhaus AD. 1998. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 74:57-66. https://doi.org/10.1016/S0166-0934(98)00071-8
37. Munster VJ, Baas C, Lexmond P, Bestebroer TM, Guldemeester J, Beyer WE, de Wit E, Schutten M, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2009. Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol 47:666-673. https://doi.org/10.1128/JCM.01625-08